$RGC Huge News! Regencell Bioscience Holdings Limited Announces Over $5 Million Ordinary Share Purchases by CEO
HONG KONG, May 16, 2022--(BUSINESS WIRE)--Regencell Bioscience Holdings Limited (NASDAQ: RGC) ("Regencell" or the "Company"
![](/images/icons/icon_wink.gif)
, an early-stage bioscience company focusing on the research, development and commercialization of Traditional Chinese Medicine ("TCM"
![](/images/icons/icon_wink.gif)
for the treatment of neurocognitive disorders and degenerations, as well as infectious diseases affecting people’s immune system, announced that Yat-Gai Au, the Company’s Chairman and CEO, made purchases of ordinary shares in Regencell ("Ordinary Shares"
![](/images/icons/icon_wink.gif)
totaling $5.03 million.
https://finance.yahoo.com/news/regencell-bios...00349.html